Trial Outcomes & Findings for EMG Training for Altering Activation Patterns After Stroke (NCT NCT03619772)
NCT ID: NCT03619772
Last Updated: 2026-03-20
Results Overview
Time to complete movement to 16 randomized targets
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
20 participants
Primary outcome timeframe
Baseline and 3 weeks (immediately post intervention)
Results posted on
2026-03-20
Participant Flow
Participant milestones
| Measure |
Bilateral
Participants will control game using EMG from both upper limbs.
Bilateral: Participants will control game using EMG from both upper limbs.
|
Unilateral
Participants will control game using the more impaired upper limb.
Unilateral: Participants will control game using EMG from the more impaired upper limb.
|
|---|---|---|
|
Overall Study
STARTED
|
10
|
10
|
|
Overall Study
COMPLETED
|
10
|
10
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
EMG Training for Altering Activation Patterns After Stroke
Baseline characteristics by cohort
| Measure |
Bilateral
n=10 Participants
Participants will control game using EMG from both upper limbs.
Bilateral: Participants will control game using EMG from both upper limbs.
|
Unilateral
n=10 Participants
Participants will control game using the more impaired upper limb.
Unilateral: Participants will control game using EMG from the more impaired upper limb.
|
Total
n=20 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
59.4 years
STANDARD_DEVIATION 26.9 • n=154 Participants
|
60.4 years
STANDARD_DEVIATION 24.3 • n=151 Participants
|
59.9 years
STANDARD_DEVIATION 25.6 • n=305 Participants
|
|
Sex: Female, Male
Female
|
6 Participants
n=154 Participants
|
2 Participants
n=151 Participants
|
8 Participants
n=305 Participants
|
|
Sex: Female, Male
Male
|
4 Participants
n=154 Participants
|
8 Participants
n=151 Participants
|
12 Participants
n=305 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
|
Race (NIH/OMB)
Black or African American
|
5 Participants
n=154 Participants
|
9 Participants
n=151 Participants
|
14 Participants
n=305 Participants
|
|
Race (NIH/OMB)
White
|
5 Participants
n=154 Participants
|
1 Participants
n=151 Participants
|
6 Participants
n=305 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
1 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
1 Participants
n=305 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
9 Participants
n=154 Participants
|
10 Participants
n=151 Participants
|
19 Participants
n=305 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=154 Participants
|
0 Participants
n=151 Participants
|
0 Participants
n=305 Participants
|
|
Region of Enrollment
United States
|
10 participants
n=154 Participants
|
10 participants
n=151 Participants
|
20 participants
n=305 Participants
|
|
Chedoke Stage of Hand Score
Chedoke Hand Score of 4
|
8 Participants
n=154 Participants
|
7 Participants
n=151 Participants
|
15 Participants
n=305 Participants
|
|
Chedoke Stage of Hand Score
Chedoke Hand Score of 5
|
2 Participants
n=154 Participants
|
3 Participants
n=151 Participants
|
5 Participants
n=305 Participants
|
|
Side of Impairment
Right Affected
|
5 Participants
n=154 Participants
|
6 Participants
n=151 Participants
|
11 Participants
n=305 Participants
|
|
Side of Impairment
Left Affected
|
5 Participants
n=154 Participants
|
4 Participants
n=151 Participants
|
9 Participants
n=305 Participants
|
PRIMARY outcome
Timeframe: Baseline and 3 weeks (immediately post intervention)Time to complete movement to 16 randomized targets
Outcome measures
| Measure |
Unilateral
n=10 Participants
Participants will control game using the more impaired upper limb.
Unilateral: Participants will control game using EMG from the more impaired upper limb.
|
Bilateral
n=10 Participants
Participants will control game using EMG from both upper limbs.
Bilateral: Participants will control game using EMG from both upper limbs.
|
|---|---|---|
|
Change in Mean Completion Time for Timed Test
|
-7.5 Minutes
Standard Error 2.4
|
-2.8 Minutes
Standard Error 2.2
|
Adverse Events
Bilateral
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Unilateral
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place